Cohort (LSE:CHRT) Research & Development: £0.0 Mil (TTM As of Oct. 2025)


LSE:CHRT Cohort PLC LSE:CHRT
94 GF Score
Price £11.82
GF Value £10.77
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cohort Research & Development?

Cohort LSE:CHRT -0.34% 94 Research & Development is £0.0 Mil as of Oct. 2025. GuruFocus rates LSE:CHRT with a GF Score™ of 94/100 and a GF Value™ of £10.77 (Fairly Valued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cohort's Research & Development for the six months ended in Oct. 2025 was £0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Oct. 2025 was £0.0 Mil.

Cohort  (LSE:CHRT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cohort Research & Development Related Terms

Cohort Research & Development Historical Data

* Premium members only.

The historical data trend for Cohort's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cohort Research & Development Chart

Cohort Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cohort Semi-Annual Data
Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24 Oct24 Apr25 Oct25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:CHRT
94GF Score
Cohort PLC LSE:CHRT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cohort Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Oct. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.0 Mil mean?
Cohort (LSE:CHRT) has a Research & Development of £0.0 Mil as of Oct. 2025. Research and development expense is the total cost for research and development activities. View historical data on Cohort and its competitors.
Is Cohort's Research & Development too high?
Cohort's current Research & Development is £0.0 Mil. Overall, Cohort has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cohort's Research & Development compare to GE and RTX?
Cohort's Research & Development of £0.0 Mil can be compared against companies in the Aerospace & Defense industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Aerospace & Defense company?
A good Research & Development depends on the Aerospace & Defense industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cohort and its competitors. Cohort's current Research & Development is £0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cohort stock overvalued right now?
Based on GuruFocus' analysis, Cohort (LSE:CHRT) is currently considered Fairly Valued. The stock's GF Value™ is £10.77, compared to a current price of £11.82 — trading 9.7% above its estimated fair value. The current Research & Development is £0.0 Mil. Cohort's overall GF Score™ is 94/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cohort (LSE:CHRT), the current Research & Development is £0.0 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cohort (LSE:CHRT) Overvalued in 2026?

Based on GuruFocus' analysis, Cohort stock appears to be overvalued. The current stock price of £11.82 is trading 9.7% above its estimated GF Value™ of £10.77. GuruFocus considers Cohort to be Fairly Valued.

Key valuation signals for LSE:CHRT:

  • Research & Development: £0.0 Mil
  • GF Value™: £10.77 vs. price of £11.82 (9.7% above fair value)
  • GF Score™: 94/100 with 4 warning signs

No single metric tells the full story. See the LSE:CHRT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cohort Business Description

Address One Waterside Drive, Arlington Business Park, Theale, Reading, GBR, RG7 4SW
Cohort PLC is the parent company of seven businesses that provide services and products for customers in the defence, security, and related sectors in the United Kingdom and international markets. Its businesses include Chess, EID, ELAC Sonar, EM Solutions, MASS, MCL and SEA. The company has operations in UK, Portugal, Australia and Canada.
94GF Score

Get the complete analysis for LSE:CHRT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£11.82
Price
£10.77
GF Value